Literature DB >> 32294597

The emerging role of XBP1 in cancer.

Shanshan Chen1, Jing Chen2, Xin Hua3, Yue Sun3, Rui Cui3, Jun Sha3, Xiaoli Zhu4.   

Abstract

X-box binding protein 1 (XBP1) is a unique basic-region leucine zipper (bZIP) transcription factor whose dynamic form is controlled by an alternative splicing response upon disturbance of homeostasis in the endoplasmic reticulum (ER) and activation of the unfolded protein response (UPR). XBP1 was first distinguished as a key regulator of major histocompatibility complex (MHC) class II gene expression in B cells. XBP1 communicates with the foremost conserved signalling component of the UPR and is essential for cell fate determination in response to ER stress (ERS). Here, we review recent advances in our understanding of this multifaceted translation component in cancer. In this review, we briefly discuss the role of XBP1 mediators in the UPR and the transcriptional function of XBP1. In addition, we describe how XBP1 operates as a key factor in tumour progression and metastasis. We mainly review XBP1's expression, function and prognostic value in research on solid tumours. Finally, we discuss multiple approaches, especially those involving XBP1, that overcome the immunosuppressive effect of the UPR in cancer that could potentially be useful as antitumour therapies.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cancer; Endoplasmic reticulum stress; Inositol-requiring enzyme 1; Unfolded protein response; X-box binding protein 1

Mesh:

Substances:

Year:  2020        PMID: 32294597     DOI: 10.1016/j.biopha.2020.110069

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  17 in total

1.  Silencing circANKRD36 inhibits streptozotocin-induced insulin resistance and inflammation in diabetic rats by targeting miR-145 via XBP1.

Authors:  Jinger Lu; Linrong Pang; Bo Zhang; Zhigang Gong; Chunhui Song
Journal:  Inflamm Res       Date:  2021-05-12       Impact factor: 4.575

2.  Identification of Ferroptotic Genes in Spinal Cord Injury at Different Time Points: Bioinformatics and Experimental Validation.

Authors:  Yu Kang; Qiangwei Li; Rui Zhu; Shuang Li; Xin Xu; Xuanming Shi; Zongsheng Yin
Journal:  Mol Neurobiol       Date:  2022-07-07       Impact factor: 5.682

3.  The X box binding protein 1/C/EBP homologous protein pathway induces apoptosis of endothelial cells under hyperglycemia.

Authors:  Maoshun Tang; Yi Zheng; Jianping Li; Yuanlang Hu
Journal:  Exp Ther Med       Date:  2022-05-18       Impact factor: 2.751

4.  ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress.

Authors:  Rossella Benedetti; Maria Anele Romeo; Andrea Arena; Maria Saveria Gilardini Montani; Livia Di Renzo; Gabriella D'Orazi; Mara Cirone
Journal:  Cell Death Discov       Date:  2022-06-25

Review 5.  Interconnected Adaptive Responses: A Way Out for Cancer Cells to Avoid Cellular Demise.

Authors:  Gabriella D'Orazi; Mara Cirone
Journal:  Cancers (Basel)       Date:  2022-06-03       Impact factor: 6.575

6.  X-box binding protein 1 (XBP1): a potential role in chemotherapy response, clinical pathologic features, non-inflamed tumour microenvironment for breast cancer.

Authors:  Zhipeng Zhu; Hongliang Zhan; Anran Sun; Heqing Huang; Baisheng Chen; Fuxing Zhang
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

7.  Genome-wide analysis of somatic noncoding mutation patterns in cancer.

Authors:  Alex B Wang; Christian Fagre; Anran Tang; Felix Dietlein; Nicolle J M Besselink; Edwin Cuppen; Chunliang Li; Shamil R Sunyaev; James T Neal; Eliezer M Van Allen
Journal:  Science       Date:  2022-04-08       Impact factor: 63.714

8.  Novel Quinazolinyl Compounds as Endoribonuclease Inositol Requiring Enzyme 1 (IRE 1α) Inhibitors for Treating Cancer.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-01-11       Impact factor: 4.345

9.  A novel XBP1 variant is highly enriched in cancer tissues and is specifically required for cancer cell survival.

Authors:  Yongwang Zhong; Wenjing Yan; Jingjing Ruan; Mike Fang; Rena G Lapidus; Shaojun Du; Shengyun Fang
Journal:  Biochem Biophys Res Commun       Date:  2021-05-24       Impact factor: 3.322

10.  Triazoloacridone C-1305 impairs XBP1 splicing by acting as a potential IRE1α endoribonuclease inhibitor.

Authors:  Sylwia Bartoszewska; Jarosław Króliczewski; David K Crossman; Aneta Pogorzelska; Maciej Bagiński; James F Collawn; Rafal Bartoszewski
Journal:  Cell Mol Biol Lett       Date:  2021-03-17       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.